Human Papillomavirus (HPV) infection is the most common sexually transmitted disease, as 80% of sexually active people will be infected at some point during their lifetime. In most cases, infections are temporary and resolve spontaneously.
Last October 6th, the subject addressed in the webinar was the management of these patients. It was organized by the laboratory specialized in women’s health, Procare Health, on Ginecare the continuing medical education platform. The webinar consisted of the viewing of one of the recorded sessions of the 35th Virtual and Semi-presential Congress of the Section of Gynecologic Oncology and Breast Pathology of the SEGO, given by doctors Santiago Palacios, Luis Serrano and Damián Dexeus. The experts presented their experience on the efficacy of the use of the gel based on Coriolus versicolor in HPV+ women.
Understanding clinical practice in the management of infection.
Understanding clinical practice in the management of infection. Santiago Palacios, head of the Institute Palacios Health and Women’s Medicine, presented the results of Papilloscopia. Papilloscopia is a national survey on the status of HPV management in women over 30 years of age in Spain conducted between 2018 and 2019. More than 160 gynecologists participated and performed more than 157 monthly explorations and cytological studies, the survey showed that 28% of cytologies presented an alteration produced by HPV.
After receiving a cytology with a low-grade cytology result, more than 81.7% of physicians perform colposcopy; 51.8% complete the study with an HPV test; 14% a biopsy; and 32.3% treat the patient with the Coriolus versicolor-based gel ‘Papilocare’ (Procare Health), according to the Papilloscopia survey.
In the case of a suspicious lesion detected by colposcopy, a biopsy of the area is performed in 40% of cases. As for conization, the frequency of CIN I is 55%. Finally, according to 64% of those consulted, CIN I lesions persist for two or more years.
Clinical case 1: HPV-dependent genital warts
Dr. Luis Serrano, head of the Cervical Therapy unit of HM Gabinete Velázquez in Madrid, presented the clinical case of a patient with a genital condyloma-wart caused by HPV. After the failure of treatment with Imiquimod and Podophyllotoxin, the application of ‘Papilocare’ gel (Procare Health) after laser vaporization achieved a favorable evolution, with disappearance of the lesional plaque.
Case report 2: post-conization adjuvant treatment
Dr. Damian Dexeus, medical director of the Women’s clinic in Barcelona, shared the clinical case of a 34-year-old woman who attended her gynecological check-up appointment. On performing colposcopy and observing a pathological area, a biopsy was performed and revealed a high-grade squamous intraepithelial lesion CIN III.
After performing an outpatient Fisher loop conization, the patient was discharged with an indication to return to the clinic for a first clinical check-up after four weeks. During this period of time, the patient used Papilocare vaginal mucosal repair gel to accelerate the epithelialization process and reduce the risk of bleeding. “A vaginal gel with Coriolus versicolor appears to be a safe option to accelerate post-conization epithelialization,” Dexeus concluded.
Ginecare, Continuing Medical Education
Yann Gaslain, founder and CEO of Procare Health, also participated in this webinar and also mentioned the announcement of the Javier Cortés-Santiago Dexeus Research Award in lower genital tract pathology, endowed with 10,000 euros, which will be awarded at the next ONCOSEGO Congress. The bases will be communicated soon, according to Yann Gaslain.
This webinar is the sixth one organized this year by Ginecare Continuing Medical Education, a platform that hosts continuous information for doctors, nurses, midwives and pharmacists. It has been conducted by Dr. Anna Mallafré, Gynecologist and Medical Advisor of Procare Health.
In Ginecare FMC users can find online courses, scientific publications, free webinars, relevant news, videos of lectures and conferences, and interviews with leading physicians.